Company / Financials
Pulmonx Corp Financials
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$83.8M
FY2025 · +22.0% YoY
Net Income
-$56.4M
FY2025 · +7.3% YoY
Profit Margin
-67.3%
FY2025 · net income / revenue
ROE
-65.7%
FY2025 · return on equity
Total Assets
$129.3M
FY2025
Total Debt
$37.0M
0.43x debt/equity
Equity
$85.8M
FY2025
ROA
-43.6%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 0.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$83.8M+22.0% YoYNet Income HistoryProfit after all expenses and taxes-$56.4M+7.3% YoYGross Profit HistoryRevenue minus cost of goods sold$62.0M+22.2% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$21.8M+21.6% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$57.7M+6.8% YoYSG&A Expense HistorySelling, general, and administrative expenses$102.1M+8.0% YoYR&D Expense HistoryResearch and development spending$17.6M-2.8% YoYInterest Expense HistoryCost of borrowing and debt obligations$1.1MIncome Tax HistoryTotal income tax expense$500.0K-12.4% YoYEPS (Basic) HistoryBasic earnings per share-$1.44+10.0% YoY